By Exec Edge Editorial Staff Exec Edge spoke with Frantz Saintellemy, Incoming CEO of LeddarTech, which is going public via a merger with Prospector Capital Corp. (Nasdaq: PRSR). ExecEdge: Welcome, Frantz. Let’s start off by learning a little more about...

By John Jannarone of PE Edge Private-equity firm TZP Group has created a new star, investing in two of the industry’s top innovators to form DanceOne, marking the largest institutional dance investment in history while creating the world’s biggest dance...

By Thomas Green Bonaventure —an integrated alternative asset management firm with over $2.3 billion of assets under management— said it recently acquired a 121 unit Class-A multifamily community in downtown Norfolk, Va. with its perpetual life multifamily fund.  As part of...

    By Healthcare Edge Editorial Staff SAB Biotherapeutics, Inc. (Nasdaq: SABS), which is trying to slow down the progression of type 1 diabetes, said it started trials of SAB-142 on humans in Australia. SAB-142 is the first fully-human anti-thymocyte...

PE Edge and Exec Edge are please to provide complete video coverage of the third annual Palm Beach CorpGov Forum, which was held on Nov. 8, featuring a full day of panels and fireside chats. The event was composed of over...

Healthcare Edge and Exec Edge are please to provide complete video coverage of the third annual Palm Beach CorpGov Forum, which was held on Nov. 8, featuring a full day of panels and fireside chats. The event was composed of over...

PE Edge and Exec Edge are please to provide complete video coverage of the third annual Palm Beach CorpGov Forum, which was held on Wednesday, Nov. 8, featuring a full day of panels and fireside chats. The event was composed of...

The new book for aspiring day traders uses honesty to dispel myths and discourage anyone looking for overnight success. By Exec Edge Editorial Staff The world of day-trading is often perceived as a high-stakes gamble, with sensational stories of overnight...

By Karen E. Roman Alladapt Immunotherapeutics, Inc., a biopharmaceutical company developing treatment for Immunoglobulin E-mediated food allergy, said it received fast track designation by the U.S. Food and Drug Administration for ADP101, its multi-food oral immunotherapy. ADP101 is designed to...

IPO Edge hosted a fireside chat with Chief Executive Officer Michael Seifert of PublicSq (NYSE: PSQH) at the 3rd Annual Palm Beach CorpGov Forum in West Palm Beach, Florida. Mr. Seifert was joined by IPO Edge Editor-in-Chief John Jannarone and they...